Bendamustine, bortezomib and prednisone for the treatment of patients with newly diagnosed multiple myeloma: results of a prospective phase 2 Spanish/PETHEMA trial
暂无分享,去创建一个
Á. Payer | J. Miguel | N. Puig | A. Oriol | E. Ocio | J. Bladé | J. Lahuerta | J. de la Rubia | L. Rosiñol | M. Mateos | L. Palomera | F. de Arriba | J. Martínez-López | A. Alegre | R. Martínez | M. Echeveste | J. Sarrá | Rebeca Iglesias | A. Chinea | G. Ramírez | J. Martín